Immunome, Inc.IMNMNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+95.7%
5Y CAGR+91.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+95.7%/yr
vs +35.6%/yr prior
5Y CAGR
+91.7%/yr
Recent acceleration
Acceleration
+60.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
25.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $174.33M | +34.6% |
| 2024 | $129.54M | +461.1% |
| 2023 | $23.09M | -0.8% |
| 2022 | $23.27M | +64.9% |
| 2021 | $14.11M | +109.6% |
| 2020 | $6.73M | -23.7% |
| 2019 | $8.82M | +28.3% |
| 2018 | $6.88M | - |